nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0857	0.248	CbGbCtD
Sibutramine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0649	0.188	CbGbCtD
Sibutramine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0557	0.161	CbGbCtD
Sibutramine—CYP3A4—Prednisolone—ankylosing spondylitis	0.055	0.159	CbGbCtD
Sibutramine—CYP3A4—Prednisone—ankylosing spondylitis	0.0519	0.15	CbGbCtD
Sibutramine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0324	0.0937	CbGbCtD
Sibutramine—Stomatitis—Methotrexate—ankylosing spondylitis	0.000621	0.000949	CcSEcCtD
Sibutramine—Angiopathy—Prednisone—ankylosing spondylitis	0.000621	0.000949	CcSEcCtD
Sibutramine—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000619	0.000946	CcSEcCtD
Sibutramine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000619	0.000946	CcSEcCtD
Sibutramine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000618	0.000945	CcSEcCtD
Sibutramine—Malaise—Betamethasone—ankylosing spondylitis	0.000617	0.000943	CcSEcCtD
Sibutramine—Malaise—Dexamethasone—ankylosing spondylitis	0.000617	0.000943	CcSEcCtD
Sibutramine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000615	0.00094	CcSEcCtD
Sibutramine—Oedema—Triamcinolone—ankylosing spondylitis	0.000615	0.00094	CcSEcCtD
Sibutramine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000615	0.000939	CcSEcCtD
Sibutramine—Vertigo—Betamethasone—ankylosing spondylitis	0.000615	0.000939	CcSEcCtD
Sibutramine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000614	0.000938	CcSEcCtD
Sibutramine—Syncope—Dexamethasone—ankylosing spondylitis	0.000614	0.000938	CcSEcCtD
Sibutramine—Syncope—Betamethasone—ankylosing spondylitis	0.000614	0.000938	CcSEcCtD
Sibutramine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000611	0.000934	CcSEcCtD
Sibutramine—Infection—Triamcinolone—ankylosing spondylitis	0.000611	0.000934	CcSEcCtD
Sibutramine—Sweating—Methotrexate—ankylosing spondylitis	0.000611	0.000933	CcSEcCtD
Sibutramine—Infection—Methylprednisolone—ankylosing spondylitis	0.00061	0.000932	CcSEcCtD
Sibutramine—Haematuria—Methotrexate—ankylosing spondylitis	0.000608	0.000928	CcSEcCtD
Sibutramine—Shock—Triamcinolone—ankylosing spondylitis	0.000605	0.000925	CcSEcCtD
Sibutramine—Insomnia—Prednisolone—ankylosing spondylitis	0.000605	0.000925	CcSEcCtD
Sibutramine—Alopecia—Prednisone—ankylosing spondylitis	0.000605	0.000924	CcSEcCtD
Sibutramine—Shock—Methylprednisolone—ankylosing spondylitis	0.000604	0.000923	CcSEcCtD
Sibutramine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000601	0.000919	CcSEcCtD
Sibutramine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000601	0.000919	CcSEcCtD
Sibutramine—Epistaxis—Methotrexate—ankylosing spondylitis	0.000601	0.000918	CcSEcCtD
Sibutramine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000601	0.000918	CcSEcCtD
Sibutramine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000601	0.000918	CcSEcCtD
Sibutramine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000599	0.000916	CcSEcCtD
Sibutramine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000596	0.000911	CcSEcCtD
Sibutramine—Malnutrition—Prednisone—ankylosing spondylitis	0.000596	0.00091	CcSEcCtD
Sibutramine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000595	0.000909	CcSEcCtD
Sibutramine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000594	0.000907	CcSEcCtD
Sibutramine—Convulsion—Betamethasone—ankylosing spondylitis	0.000593	0.000906	CcSEcCtD
Sibutramine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000593	0.000906	CcSEcCtD
Sibutramine—Hypertension—Betamethasone—ankylosing spondylitis	0.000591	0.000903	CcSEcCtD
Sibutramine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000591	0.000903	CcSEcCtD
Sibutramine—Myalgia—Betamethasone—ankylosing spondylitis	0.000582	0.00089	CcSEcCtD
Sibutramine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000582	0.00089	CcSEcCtD
Sibutramine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00058	0.000887	CcSEcCtD
Sibutramine—Anxiety—Betamethasone—ankylosing spondylitis	0.00058	0.000887	CcSEcCtD
Sibutramine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000575	0.000879	CcSEcCtD
Sibutramine—Discomfort—Betamethasone—ankylosing spondylitis	0.000575	0.000879	CcSEcCtD
Sibutramine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000575	0.000878	CcSEcCtD
Sibutramine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000574	0.000877	CcSEcCtD
Sibutramine—Pain—Prednisolone—ankylosing spondylitis	0.000572	0.000874	CcSEcCtD
Sibutramine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000572	0.000874	CcSEcCtD
Sibutramine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000568	0.000867	CcSEcCtD
Sibutramine—Vision blurred—Prednisone—ankylosing spondylitis	0.000561	0.000858	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000561	0.000857	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000559	0.000855	CcSEcCtD
Sibutramine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000558	0.000853	CcSEcCtD
Sibutramine—Oedema—Dexamethasone—ankylosing spondylitis	0.000558	0.000853	CcSEcCtD
Sibutramine—Oedema—Betamethasone—ankylosing spondylitis	0.000558	0.000853	CcSEcCtD
Sibutramine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000558	0.000853	CcSEcCtD
Sibutramine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000557	0.00085	CcSEcCtD
Sibutramine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000555	0.000849	CcSEcCtD
Sibutramine—Infection—Dexamethasone—ankylosing spondylitis	0.000555	0.000848	CcSEcCtD
Sibutramine—Infection—Betamethasone—ankylosing spondylitis	0.000555	0.000848	CcSEcCtD
Sibutramine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000553	0.000845	CcSEcCtD
Sibutramine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000553	0.000844	CcSEcCtD
Sibutramine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000551	0.000843	CcSEcCtD
Sibutramine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000551	0.000842	CcSEcCtD
Sibutramine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000551	0.000842	CcSEcCtD
Sibutramine—Anaemia—Prednisone—ankylosing spondylitis	0.000551	0.000841	CcSEcCtD
Sibutramine—Shock—Dexamethasone—ankylosing spondylitis	0.000549	0.000839	CcSEcCtD
Sibutramine—Shock—Betamethasone—ankylosing spondylitis	0.000549	0.000839	CcSEcCtD
Sibutramine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000549	0.000838	CcSEcCtD
Sibutramine—Agitation—Prednisone—ankylosing spondylitis	0.000548	0.000837	CcSEcCtD
Sibutramine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000547	0.000835	CcSEcCtD
Sibutramine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000547	0.000835	CcSEcCtD
Sibutramine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000545	0.000833	CcSEcCtD
Sibutramine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000545	0.000833	CcSEcCtD
Sibutramine—Angioedema—Prednisone—ankylosing spondylitis	0.000544	0.000832	CcSEcCtD
Sibutramine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000542	0.000828	CcSEcCtD
Sibutramine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00054	0.000826	CcSEcCtD
Sibutramine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00054	0.000825	CcSEcCtD
Sibutramine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00054	0.000825	CcSEcCtD
Sibutramine—Malaise—Prednisone—ankylosing spondylitis	0.000537	0.000821	CcSEcCtD
Sibutramine—Vertigo—Prednisone—ankylosing spondylitis	0.000535	0.000818	CcSEcCtD
Sibutramine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000535	0.000817	CcSEcCtD
Sibutramine—Syncope—Prednisone—ankylosing spondylitis	0.000534	0.000816	CcSEcCtD
Sibutramine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000533	0.000815	CcSEcCtD
Sibutramine—Anorexia—Betamethasone—ankylosing spondylitis	0.000532	0.000813	CcSEcCtD
Sibutramine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000532	0.000813	CcSEcCtD
Sibutramine—Urticaria—Prednisolone—ankylosing spondylitis	0.000532	0.000812	CcSEcCtD
Sibutramine—Pain—Triamcinolone—ankylosing spondylitis	0.000526	0.000804	CcSEcCtD
Sibutramine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000524	0.0008	CcSEcCtD
Sibutramine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000522	0.000797	CcSEcCtD
Sibutramine—Hypotension—Betamethasone—ankylosing spondylitis	0.000522	0.000797	CcSEcCtD
Sibutramine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000519	0.000793	CcSEcCtD
Sibutramine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000517	0.000789	CcSEcCtD
Sibutramine—Convulsion—Prednisone—ankylosing spondylitis	0.000516	0.000789	CcSEcCtD
Sibutramine—Hypertension—Prednisone—ankylosing spondylitis	0.000514	0.000786	CcSEcCtD
Sibutramine—Chills—Methotrexate—ankylosing spondylitis	0.000513	0.000784	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000509	0.000777	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000509	0.000777	CcSEcCtD
Sibutramine—Arthralgia—Prednisone—ankylosing spondylitis	0.000507	0.000775	CcSEcCtD
Sibutramine—Myalgia—Prednisone—ankylosing spondylitis	0.000507	0.000775	CcSEcCtD
Sibutramine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000507	0.000775	CcSEcCtD
Sibutramine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000506	0.000773	CcSEcCtD
Sibutramine—Anxiety—Prednisone—ankylosing spondylitis	0.000505	0.000772	CcSEcCtD
Sibutramine—Alopecia—Methotrexate—ankylosing spondylitis	0.000505	0.000772	CcSEcCtD
Sibutramine—Insomnia—Betamethasone—ankylosing spondylitis	0.000505	0.000772	CcSEcCtD
Sibutramine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000505	0.000772	CcSEcCtD
Sibutramine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000502	0.000767	CcSEcCtD
Sibutramine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000501	0.000766	CcSEcCtD
Sibutramine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000501	0.000766	CcSEcCtD
Sibutramine—Discomfort—Prednisone—ankylosing spondylitis	0.000501	0.000766	CcSEcCtD
Sibutramine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000498	0.000761	CcSEcCtD
Sibutramine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000493	0.000753	CcSEcCtD
Sibutramine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000491	0.000751	CcSEcCtD
Sibutramine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000491	0.000751	CcSEcCtD
Sibutramine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000489	0.000747	CcSEcCtD
Sibutramine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000488	0.000745	CcSEcCtD
Sibutramine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000488	0.000745	CcSEcCtD
Sibutramine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000486	0.000743	CcSEcCtD
Sibutramine—Oedema—Prednisone—ankylosing spondylitis	0.000486	0.000743	CcSEcCtD
Sibutramine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000486	0.000743	CcSEcCtD
Sibutramine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000485	0.000742	CcSEcCtD
Sibutramine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000485	0.000742	CcSEcCtD
Sibutramine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000485	0.000742	CcSEcCtD
Sibutramine—Infection—Prednisone—ankylosing spondylitis	0.000483	0.000738	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000482	0.000737	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000482	0.000737	CcSEcCtD
Sibutramine—Back pain—Methotrexate—ankylosing spondylitis	0.000482	0.000736	CcSEcCtD
Sibutramine—Shock—Prednisone—ankylosing spondylitis	0.000478	0.000731	CcSEcCtD
Sibutramine—Pain—Dexamethasone—ankylosing spondylitis	0.000477	0.00073	CcSEcCtD
Sibutramine—Pain—Betamethasone—ankylosing spondylitis	0.000477	0.00073	CcSEcCtD
Sibutramine—Tachycardia—Prednisone—ankylosing spondylitis	0.000475	0.000725	CcSEcCtD
Sibutramine—Skin disorder—Prednisone—ankylosing spondylitis	0.000472	0.000722	CcSEcCtD
Sibutramine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00047	0.000718	CcSEcCtD
Sibutramine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000469	0.000717	CcSEcCtD
Sibutramine—Anorexia—Prednisone—ankylosing spondylitis	0.000463	0.000708	CcSEcCtD
Sibutramine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000462	0.000706	CcSEcCtD
Sibutramine—Anaemia—Methotrexate—ankylosing spondylitis	0.00046	0.000703	CcSEcCtD
Sibutramine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00046	0.000703	CcSEcCtD
Sibutramine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00046	0.000703	CcSEcCtD
Sibutramine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000457	0.000698	CcSEcCtD
Sibutramine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000457	0.000698	CcSEcCtD
Sibutramine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000453	0.000693	CcSEcCtD
Sibutramine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000452	0.000691	CcSEcCtD
Sibutramine—Malaise—Methotrexate—ankylosing spondylitis	0.000449	0.000686	CcSEcCtD
Sibutramine—Vertigo—Methotrexate—ankylosing spondylitis	0.000447	0.000684	CcSEcCtD
Sibutramine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000446	0.000681	CcSEcCtD
Sibutramine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000444	0.000678	CcSEcCtD
Sibutramine—Urticaria—Betamethasone—ankylosing spondylitis	0.000444	0.000678	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000443	0.000677	CcSEcCtD
Sibutramine—Dizziness—Prednisolone—ankylosing spondylitis	0.000442	0.000676	CcSEcCtD
Sibutramine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000442	0.000675	CcSEcCtD
Sibutramine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000441	0.000674	CcSEcCtD
Sibutramine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000441	0.000674	CcSEcCtD
Sibutramine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000441	0.000674	CcSEcCtD
Sibutramine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000441	0.000674	CcSEcCtD
Sibutramine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000441	0.000673	CcSEcCtD
Sibutramine—Insomnia—Prednisone—ankylosing spondylitis	0.00044	0.000672	CcSEcCtD
Sibutramine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000437	0.000667	CcSEcCtD
Sibutramine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000435	0.000665	CcSEcCtD
Sibutramine—Cough—Methotrexate—ankylosing spondylitis	0.000434	0.000664	CcSEcCtD
Sibutramine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000434	0.000664	CcSEcCtD
Sibutramine—Convulsion—Methotrexate—ankylosing spondylitis	0.000431	0.000659	CcSEcCtD
Sibutramine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000428	0.000654	CcSEcCtD
Sibutramine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000424	0.000648	CcSEcCtD
Sibutramine—Chest pain—Methotrexate—ankylosing spondylitis	0.000424	0.000648	CcSEcCtD
Sibutramine—Myalgia—Methotrexate—ankylosing spondylitis	0.000424	0.000648	CcSEcCtD
Sibutramine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000423	0.000646	CcSEcCtD
Sibutramine—Rash—Prednisolone—ankylosing spondylitis	0.000422	0.000645	CcSEcCtD
Sibutramine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000422	0.000644	CcSEcCtD
Sibutramine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00042	0.000642	CcSEcCtD
Sibutramine—Headache—Prednisolone—ankylosing spondylitis	0.000419	0.000641	CcSEcCtD
Sibutramine—Discomfort—Methotrexate—ankylosing spondylitis	0.000419	0.00064	CcSEcCtD
Sibutramine—Constipation—Prednisone—ankylosing spondylitis	0.000416	0.000635	CcSEcCtD
Sibutramine—Confusional state—Methotrexate—ankylosing spondylitis	0.00041	0.000626	CcSEcCtD
Sibutramine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000407	0.000622	CcSEcCtD
Sibutramine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000406	0.000621	CcSEcCtD
Sibutramine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000406	0.00062	CcSEcCtD
Sibutramine—Infection—Methotrexate—ankylosing spondylitis	0.000404	0.000617	CcSEcCtD
Sibutramine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000401	0.000612	CcSEcCtD
Sibutramine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000401	0.000612	CcSEcCtD
Sibutramine—Asthenia—Betamethasone—ankylosing spondylitis	0.000401	0.000612	CcSEcCtD
Sibutramine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000398	0.000608	CcSEcCtD
Sibutramine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000398	0.000608	CcSEcCtD
Sibutramine—Nausea—Prednisolone—ankylosing spondylitis	0.000397	0.000607	CcSEcCtD
Sibutramine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000395	0.000604	CcSEcCtD
Sibutramine—Pruritus—Betamethasone—ankylosing spondylitis	0.000395	0.000604	CcSEcCtD
Sibutramine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000395	0.000603	CcSEcCtD
Sibutramine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000393	0.0006	CcSEcCtD
Sibutramine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000391	0.000598	CcSEcCtD
Sibutramine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00039	0.000597	CcSEcCtD
Sibutramine—Rash—Triamcinolone—ankylosing spondylitis	0.000388	0.000593	CcSEcCtD
Sibutramine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000388	0.000592	CcSEcCtD
Sibutramine—Anorexia—Methotrexate—ankylosing spondylitis	0.000387	0.000592	CcSEcCtD
Sibutramine—Rash—Methylprednisolone—ankylosing spondylitis	0.000387	0.000592	CcSEcCtD
Sibutramine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000387	0.000591	CcSEcCtD
Sibutramine—Urticaria—Prednisone—ankylosing spondylitis	0.000386	0.00059	CcSEcCtD
Sibutramine—Headache—Triamcinolone—ankylosing spondylitis	0.000386	0.000589	CcSEcCtD
Sibutramine—Headache—Methylprednisolone—ankylosing spondylitis	0.000385	0.000588	CcSEcCtD
Sibutramine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000384	0.000587	CcSEcCtD
Sibutramine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000384	0.000587	CcSEcCtD
Sibutramine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000382	0.000584	CcSEcCtD
Sibutramine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000382	0.000584	CcSEcCtD
Sibutramine—Hypotension—Methotrexate—ankylosing spondylitis	0.00038	0.00058	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00037	0.000566	CcSEcCtD
Sibutramine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000369	0.000564	CcSEcCtD
Sibutramine—Dizziness—Betamethasone—ankylosing spondylitis	0.000369	0.000564	CcSEcCtD
Sibutramine—Insomnia—Methotrexate—ankylosing spondylitis	0.000368	0.000562	CcSEcCtD
Sibutramine—Nausea—Triamcinolone—ankylosing spondylitis	0.000366	0.000559	CcSEcCtD
Sibutramine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000365	0.000558	CcSEcCtD
Sibutramine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000365	0.000557	CcSEcCtD
Sibutramine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000362	0.000554	CcSEcCtD
Sibutramine—Somnolence—Methotrexate—ankylosing spondylitis	0.000361	0.000552	CcSEcCtD
Sibutramine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000358	0.000547	CcSEcCtD
Sibutramine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000358	0.000547	CcSEcCtD
Sibutramine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000355	0.000542	CcSEcCtD
Sibutramine—Vomiting—Betamethasone—ankylosing spondylitis	0.000355	0.000542	CcSEcCtD
Sibutramine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000353	0.00054	CcSEcCtD
Sibutramine—Rash—Betamethasone—ankylosing spondylitis	0.000352	0.000538	CcSEcCtD
Sibutramine—Rash—Dexamethasone—ankylosing spondylitis	0.000352	0.000538	CcSEcCtD
Sibutramine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000352	0.000537	CcSEcCtD
Sibutramine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000352	0.000537	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000351	0.000536	CcSEcCtD
Sibutramine—Headache—Betamethasone—ankylosing spondylitis	0.00035	0.000535	CcSEcCtD
Sibutramine—Headache—Dexamethasone—ankylosing spondylitis	0.00035	0.000535	CcSEcCtD
Sibutramine—Asthenia—Prednisone—ankylosing spondylitis	0.000349	0.000533	CcSEcCtD
Sibutramine—Pain—Methotrexate—ankylosing spondylitis	0.000348	0.000531	CcSEcCtD
Sibutramine—Pruritus—Prednisone—ankylosing spondylitis	0.000344	0.000526	CcSEcCtD
Sibutramine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000335	0.000512	CcSEcCtD
Sibutramine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000333	0.000508	CcSEcCtD
Sibutramine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000332	0.000508	CcSEcCtD
Sibutramine—Nausea—Betamethasone—ankylosing spondylitis	0.000332	0.000507	CcSEcCtD
Sibutramine—Nausea—Dexamethasone—ankylosing spondylitis	0.000332	0.000507	CcSEcCtD
Sibutramine—Urticaria—Methotrexate—ankylosing spondylitis	0.000323	0.000493	CcSEcCtD
Sibutramine—Dizziness—Prednisone—ankylosing spondylitis	0.000322	0.000491	CcSEcCtD
Sibutramine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000321	0.000491	CcSEcCtD
Sibutramine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000321	0.000491	CcSEcCtD
Sibutramine—Vomiting—Prednisone—ankylosing spondylitis	0.000309	0.000472	CcSEcCtD
Sibutramine—Rash—Prednisone—ankylosing spondylitis	0.000307	0.000468	CcSEcCtD
Sibutramine—Dermatitis—Prednisone—ankylosing spondylitis	0.000306	0.000468	CcSEcCtD
Sibutramine—Headache—Prednisone—ankylosing spondylitis	0.000305	0.000465	CcSEcCtD
Sibutramine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000299	0.000458	CcSEcCtD
Sibutramine—Asthenia—Methotrexate—ankylosing spondylitis	0.000292	0.000446	CcSEcCtD
Sibutramine—Nausea—Prednisone—ankylosing spondylitis	0.000289	0.000441	CcSEcCtD
Sibutramine—Pruritus—Methotrexate—ankylosing spondylitis	0.000288	0.000439	CcSEcCtD
Sibutramine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000278	0.000425	CcSEcCtD
Sibutramine—Dizziness—Methotrexate—ankylosing spondylitis	0.000269	0.000411	CcSEcCtD
Sibutramine—Vomiting—Methotrexate—ankylosing spondylitis	0.000258	0.000395	CcSEcCtD
Sibutramine—Rash—Methotrexate—ankylosing spondylitis	0.000256	0.000392	CcSEcCtD
Sibutramine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000256	0.000391	CcSEcCtD
Sibutramine—Headache—Methotrexate—ankylosing spondylitis	0.000255	0.000389	CcSEcCtD
Sibutramine—Nausea—Methotrexate—ankylosing spondylitis	0.000241	0.000369	CcSEcCtD
